Feb 14
Registration statement
F-1/A
Registration statement
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Mar 20, 2025; less than a full year is stored.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BNIGF
this stock
Beroni Group Ltd
|
$217,518 | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$67.48B | +35.5% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$54.01B | +11.7% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$50.93B | +39.9% | +4.3% | 99.2 | 2.4% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
$40.66B | — | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BNIGF | -99.0% | -99.9% | -99.9% | -36.6% | -99.2% |
| SPY | +0.4% | +5.1% | +3.0% | +1.7% | +7.2% |
| vs SPY | -99.4% | -105.0% | -102.9% | -38.3% | -106.4% |